Troponina I cardíaca de alta sensibilidad y mortalidad tras cirugía de bypass coronario sin y con circulación extracorpórea: un análisis secundario del estudio VISION Cardiac Surgery

We aimed to determine whether high-sensitivity cardiac troponin I (hs-cTnI) thresholds associated with increased 30-day mortality isolated coronary artery bypass grafting (CABG) differed between those undergoing off-pump (OPCAB) and on-pump (ONCAB) CABG.

We conducted a subanalysis of patients who underwent isolated CABG in the VISION Cardiac Surgery Study. Cox regression was used to determine the hazard ratios (HRs) for mortality based on postoperative day one log-transformed hs-cTnI adjusted by EuroSCORE II, with OPCAB versus ONCAB as an interaction term. HRs were modelled as a function of hs-cTnI, and the lowest troponin associated with HR ≥ 1.00 was identified for each group.

Of the original VISION cohort, 6,505 patients underwent isolated CABG (OPCAB = 1,141, ONCAB = 5,364). Median hs-cTnI after CABG was 2,446 ng/L (IQR 1,164-5,654]), and lower after OPCAB (640 ng/L [264-1,689]) than ONCAB (2,972 ng/L [1,536-6,448], p < 0.001). There were no differences in 30-day mortality between OPCAB and ONCAB (1.7% vs 1.4%, p = 0.5). Increased log-peak hs-cTnI was associated with greater mortality after CABG (adjusted HR = 1.7 [95% CI 1.4-2.1]). The hs-cTnI threshold associated with HR ≥ 1.00 for isolated CABG was 6,549 ng/L (95% CI 3,609-8,381). OPCAB versus ONCAB had a significant interaction effect on the association between hs-cTnI and mortality (interaction p = 0.002). The hs-cTnI threshold associated with mortality after OPCAB was ≥4,708 ng/L (95% CI 581-7,177), compared to ≥ 6,806 ng/L (95% CI 4,001-13,993) after ONCAB.

The clinically significant hs-cTnI threshold after CABG associated with an increased risk of 30-day mortality above the baseline is substantially higher than defined by current guidelines, but lower in patients undergoing OPCAB compared to ONCAB.